Last reviewed · How we verify
NCT05402969: TIMAGING
Evaluation of Electrode-modiolus Distance and Cochlear Fibrosis Using Depth Sounding and Spectroscopy Tools
trial testing Transimedance Matrix measurements in Sensorineural Hearing Loss in 180 participants. Currently enrolling.
12 July 2024
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 180 |
| Start date | 12 January 2023 |
| Primary completion | 12 July 2024 |
| Estimated completion | 12 January 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Transimedance Matrix measurements
- Depth sounding and spectroscopy
- Cone Beam Computer Tomography
Conditions studied
- Sensorineural Hearing Loss — all drugs for Sensorineural Hearing Loss →
- Fibrosis — all drugs for Fibrosis →
Sponsor
University Hospital, Montpellier
Who can join
Adults 18 to 120, any sex, with Sensorineural Hearing Loss or Fibrosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cochlear fibrosis development can compromise the success and the outcomes of the cochlear implantation (CI) thus affecting the quality of life of the implanted patient. Correlating the results of the Transimpedance Matrix (TIM) measurements to the implant electrode location determined by the Cone Beam Computer Tomography (CBCT), this study aims to identify a range of TIM profiles within the implanted population, certain profiles suggesting the growth of the fibrosis tissue in cochlea
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05402969
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sensorineural Hearing Loss
Currently open trials in the same condition.
- NCT07505667 — Yiyuancong for the Treatment of Sudden Sensorineural Hearing Loss · NA · recruiting
- NCT06507007 — Genetic and Epigenetic Background of Inner Ear Dysfunction in Turner Syndrome · recruiting
- NCT07364747 — Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial · Phase 2 · recruiting
- NCT06495268 — Healthy heaAring for Healthy Ageing: Data-driven Hearing Rehabilitation Intervention to Promote Healthy Hearing · NA · active not recruiting
- NCT06226558 — Long-Term Outcomes of Children With Congenital CMV in New York State · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05402969 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 29 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05402969.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing